Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-19-007382

Director acquired 4,288,624 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BioLexis Pte Ltd. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-02-01 Grant or award : show line 1 in the form +4,288,624 $0.93 $4,000,000 65,770,503 D
Loading xslF345X03/doc4.xml…